Canada Life’s RAPT Therapeutics RAPT Stock Holding History

Canada Life’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-145	Closed	-$10K	–	2125
2024 Q1	$10K	Hold	145	–	–	﹤0.01%	2136
2023 Q4	$29K	Hold	145	–	–	﹤0.01%	2074
2023 Q3	$19K	Hold	145	–	–	﹤0.01%	2146
2023 Q2	$22K	Hold	145	–	–	﹤0.01%	2127
2023 Q1	$21K	Hold	145	–	–	﹤0.01%	2200
2022 Q4	$23K	Hold	145	–	–	﹤0.01%	2233
2022 Q3	$28K	Hold	145	–	–	﹤0.01%	2201
2022 Q2	$21K	Hold	145	–	–	﹤0.01%	2254
2022 Q1	$27K	Hold	145	–	–	﹤0.01%	2302
2021 Q4	$42K	Hold	145	–	–	﹤0.01%	2216
2021 Q3	$36K	Hold	145	–	–	﹤0.01%	2316
2021 Q2	$37K	Hold	145	–	–	﹤0.01%	2353
2021 Q1	$26K	Hold	145	–	–	﹤0.01%	2467
2020 Q4	$23K	Buy	+145	New	+$31.5K	﹤0.01%	2514

Other funds holding RAPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Canada Life's RAPT Position: Q2 2024 in Review

Canada Life sold out of RAPT Therapeutics (RAPT) in Q2 2024, closing a stake of 145 shares — an estimated $10K sold.

Canada Life first reported a position in RAPT in Q4 2020 and held it in 14 quarters. The position peaked at $42K in Q4 2021. 103 funds tracked by Wall St. Rank hold RAPT as of Q2 2024.

Canada Life reported no remaining RAPT Therapeutics position as of Q2 2024 after selling out during the quarter.
Canada Life sold 145 RAPT Therapeutics shares in Q2 2024, an estimated $10K.
Canada Life first reported a position in RAPT Therapeutics in Q4 2020 and held it in 14 quarters.
Canada Life's RAPT Therapeutics position peaked at $42K in Q4 2021.
103 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2024.

Based on Canada Life's 13F filing for Q2 2024, filed 12 Aug 2024.